Journal article · 2026
Design, Synthesis, and Preclinical Evaluation of [18F]FPON, a First-In-Class PET Tracer Targeting Proliferating Cell Nuclear Antigen for Glioblastoma Imaging
Journal of Medicinal Chemistry · Published 6 November 2026 · DOI 10.1021/acs.jmedchem.6c02235
In brief
“Design, Synthesis, and Preclinical Evaluation of [18F]FPON, a First-In-Class PET Tracer Targeting Proliferating Cell Nuclear Antigen for Glioblastoma Imaging” is a 2026 journal article by Pengcheng Zheng and 7 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 0 citations as of 17 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- References
- 41
- Authors
- 8
Abstract
Proliferating cell nuclear antigen (PCNA) is a central regulator of glioma stem cell maintenance and therapy resistance, yet no noninvasive method exists to visualize its expression in vivo. We developed [18F]FPON, a first-in-class small-molecule PET tracer targeting PCNA, derived from the clinical inhibitor AOH1996. FPON binds recombinant PCNA with a Kd of 900.8 ± 131.2… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Zheng, P., Hou, Y., Qiu, Y., Ye, P., Wei, C., Xu, Y., Wu, S., & Jin, H. (2026). Design, Synthesis, and Preclinical Evaluation of [18F]FPON, a First-In-Class PET Tracer Targeting Proliferating Cell Nuclear Antigen for Glioblastoma Imaging. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02235
MLA 9
Zheng, Pengcheng, et al. “Design, Synthesis, and Preclinical Evaluation of [18F]FPON, a First-In-Class PET Tracer Targeting Proliferating Cell Nuclear Antigen for Glioblastoma Imaging.” Journal of Medicinal Chemistry, 2026. https://doi.org/10.1021/acs.jmedchem.6c02235.
Chicago
Zheng, Pengcheng, Yuyi Hou, Yifan Qiu, Peizhen Ye, Caichuan Wei, Yanjun Xu, Sirui Wu, and Hongjun Jin. 2026. “Design, Synthesis, and Preclinical Evaluation of [18F]FPON, a First-In-Class PET Tracer Targeting Proliferating Cell Nuclear Antigen for Glioblastoma Imaging.” Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02235.
Harvard
Zheng, P. et al. (2026) ‘Design, Synthesis, and Preclinical Evaluation of [18F]FPON, a First-In-Class PET Tracer Targeting Proliferating Cell Nuclear Antigen for Glioblastoma Imaging’, Journal of Medicinal Chemistry. doi:10.1021/acs.jmedchem.6c02235.
IEEE
P. Zheng et al., “Design, Synthesis, and Preclinical Evaluation of [18F]FPON, a First-In-Class PET Tracer Targeting Proliferating Cell Nuclear Antigen for Glioblastoma Imaging,” Journal of Medicinal Chemistry, 2026, doi: 10.1021/acs.jmedchem.6c02235.
BibTeX
@article{zheng2026design,
title = {{Design, Synthesis, and Preclinical Evaluation of [18F]FPON, a First-In-Class PET Tracer Targeting Proliferating Cell Nuclear Antigen for Glioblastoma Imaging}},
author = {Zheng, Pengcheng and Hou, Yuyi and Qiu, Yifan and Ye, Peizhen and Wei, Caichuan and Xu, Yanjun and Wu, Sirui and Jin, Hongjun},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c02235},
url = {https://doi.org/10.1021/acs.jmedchem.6c02235}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- proliferating cell nuclear antigen
- PET radiotracer
- blood-brain barrier penetration
- tumor uptake
- glioma stem cells
- treatment resistance
- companion diagnostics
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Zheng, P., Hou, Y., Qiu, Y., Ye, P., Wei, C., Xu, Y., Wu, S., & Jin, H. (2026). Design, Synthesis, and Preclinical Evaluation of [18F]FPON, a First-In-Class PET Tracer Targeting Proliferating Cell Nuclear Antigen for Glioblastoma Imaging. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02235
How many times has this paper been cited?
0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Pengcheng Zheng, Yuyi Hou, Yifan Qiu, Peizhen Ye, Caichuan Wei, Yanjun Xu, Sirui Wu, Hongjun Jin.
What is the DOI of this paper?
10.1021/acs.jmedchem.6c02235, permanently at https://doi.org/10.1021/acs.jmedchem.6c02235. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.